NCT03422575 - Bioequivalence Study of 120 mg Etoricoxib Film-coated Tablets | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

March 31, 2016

Conditions

Healthy

Interventions

DRUG

Etoricoxib 120Mg Film-coated Tablet

One tablet of the Test drug was given orally (swallowed with 200 mL of water, without chewing), after an overnight fast, and after fasting (pre-dose) blood-sampling.

DRUG

Arcoxia® 120 mg Film-coated tablet (Frosst Iberica S.A., Spain for Merck Sharp & Dohme (Australia) Pty Limited, Australia, registered by PT. Schering-Plough Indonesia Tbk)

One tablet of the Reference drug was given orally (swallowed with 200 mL of water, without chewing), after an overnight fast, and after fasting (pre-dose) blood-sampling.

Trial Locations (1)

12430

PT Equilab International, Jakarta